Genetic analysis can improve depression therapy

The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme differences in the levels of escitalopram achieved in patients, according to a new study published in The American Journal of Psychiatry. Prescribing the dose of escitalopram based on a patient's specific genetic constitution would greatly improve therapeutic outcomes. The study was conducted at Karolinska Institutet in Sweden in association with researchers at Diakonhjemmet Hospital in Oslo, Norway.

Genetic analysis can improve depression therapy

The failure of drugs such as SSRIs, used to treat depression, can be a result of genetic variations in patients. Variations within the gene that encodes the CYP2C19 enzyme results in extreme ...

Fri 12 Jan 18 from Medical Xpress

Genetic analysis can improve depression therapy, Fri 12 Jan 18 from ScienceDaily

Genetic analysis can improve depression therapy, Fri 12 Jan 18 from Eurekalert

Genetic analysis can improve depression therapy, Fri 12 Jan 18 from AlphaGalileo

  • Pages: 1

Bookmark

Bookmark and Share